The increasing need for kidney transplants has led to innovations such as donor exchange programs. These programs offer transplant recipients with incompatible donors an opportunity to receive a compatible kidney. They also provide an alternative to costly desensitization protocols that have unproven long-term outcomes. Donor exchange programs have multiple options including simple two-pair exchanges to the more complicated domino exchanges or chain donations. The United States is currently limited by regional programs that provide for kidney donor exchanges. However, with the increasing public interest and need for kidney transplants, general nephrologists will be approached with questions about these donor exchange programs. The goal of this review is to discuss donor exchange programs including their role in expanding the donor pool, the various types of exchanges, regional centers that provide these programs, and the process involved in patient enrollment. A general knowledge of donor exchange programs will help providers in discussing options with patients approaching end-stage kidney disease and transplantation.
Introduction
Recent evidence indicates that even if all deceased patients in the U.S. actually donated their kidneys, the supply would still be insufficient to meet the growing demand. 1 Despite the enormous demand for deceased donor kidneys, the number of renal transplants from deceased donors performed in the U.S. has remained relatively unchanged, averaging approximately 10,000 per year for the last 7 years. 2 A significant increase in this number of deceased donors over the next few years is not expected.
Living organ donation not only promises to increase the pool of donor organs, but may improve the overall efficacy of transplantation, because organs obtained from living donors typically produce better outcomes for recipients. The half-life, or projected time to 50% graft survival of renal allografts from living donors is approximately 23 years, compared with 13 years among allografts from deceased donors. 2, 3 These advantages are even greater for patients receiving transplants prior to initiating dialysis. [4] [5] [6] [7] One key obstacle to expand the use of living donors is the incompatibility between transplant candidates and potential living donors due to blood type mismatch or the presence of pre-formed antibodies against donor antigens in the transplant candidate (also referred to as crossmatchpositive). Such incompatibility may account for 35% of potential transplant candidate-donor pairs being declined. 8, 9 This has led to the next logical step, the development of living donor exchange programs that were first proposed in 1986. 10 Such living donor exchange programs allow two incompatible transplant candidate-donor pairs to exchange living donor organs such that the resulting pairs achieve compatibility. 8, [11] [12] [13] [14] These programs, initially starting in South Korea and the Netherlands, have slowly expanded to the United States in the last decade.
The introduction and evolution of kidney donor exchange in the United States has been slow, in part due to legal questions. In 1984, the U.S. Congress passed the National Organ Transplant Act (NOTA) which provided medical criteria for organ transplantation and established a single transplant network to distribute deceased donor organs. As part of the act, NOTA prohibits any human organ transfer for "valuable consideration". Since methods such as list-exchanges and paired exchanges provide benefits to recipients who provide a living kidney donor in the exchange, this could theoretically be considered a violation of NOTA. To avoid this problem, the Living Kidney Donor Organ Donation Clarification Act in 2007 was passed to permit the development of paired exchange programs.
There are several other concerns in regards to kidney exchange programs. Ethical issues arise when particular groups are deprived by these paired exchanges. Another issue is the resources needed for paired exchanges that are often neglected. This review will describe kidney exchange programs and the process involved.
Types of Incompatibility
One of the major barriers to living donation between a donor and recipient is either blood type mismatch or the presence of a positive crossmatch. A positive crossmatch is due to the presence of a pre-existing antibody to a donor antigen. To get around this, protocols have been developed for desensitization of recipients with high pre-formed donor-specific antibodies or for ABOincompatible transplants.
Desensitization protocols were developed to reduce the heightened risk of antibody-mediated rejection in recipients with a positive crossmatch to their donor. Several different methods reducing pre-transplant antibodies have been described. Several centers use plasmapheresis (PP) alternating with intravenous immune globulin (IVIG) prior to transplantation until the crossmatch becomes negative. 15, 16 Jordan et al. used IVIG alone to convert their crossmatch status from positive to negative. 17 Another method uses rituximab and IVIG to decrease the total panel reactive antibody (PRA) level while awaiting transplant. 18 However, high titers of preformed donor-specific antibodies that are likely resistant to reduction by current protocols precludes patients from being eligible for desensitization. Also, not all costs associated with desensitization are covered by insurance companies, so this may not be an option for many patients.
Experience with ABO-incompatible transplants has shown improving outcomes over time.
Initial experience showed poor outcomes and the need for splenectomy in these types of transplants to avoid severe AMR. 19 However, protocols have emerged using PP/IVIG and rituximab 20 that eliminate the need for splenectomy. These newer protocols have made ABOincompatible transplantation cost-effective in the long-term, compared with the costs associated with dialysis. 21 However, there are limited data for long-term graft survival, and these individuals are more likely to experience AMR 15, 22, 23 , which has been associated with a higher incidence of transplant glomerulopathy. 24 Therefore, desensitization is not an option for all patients.
Types of Donor Exchanges
Multiple permutations of donor exchange have been described and implemented to accommodate the most number of recipients. Rapaport first described kidney paired donation where two incompatible donor-recipient pairs exchange donors to create two compatible pairs ( Figure 1 ).
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In a donor exchange program, if the eligibility criteria for incompatibility was strictly limited to blood type, only type A and B pairs would mutually benefit from paired donation. However, if the eligibility criteria for incompatibility were expanded to crossmatch-positive donor-recipient pairs, then blood type AB recipients and type O donors also benefit from paired donation.
Therefore, exchange programs allow for both blood type mismatched and crossmatch-positive donor-recipient pairs.
To expand the potential pool of donors and potential matches, other variations of paired donation have been conducted. Paired donations may include 3-way or higher exchanges, similar to the two-pair donation Rapaport described. 25 Delmonico et al. described a program involving live donor/deceased donor list exchange where the incompatible living donor donates to an individual on the deceased donor list. In return, this donor's incompatible recipient is moved to the top of the list. 26 One example where ethical issues arise is the list-exchange where an incompatible donor of a common blood type (e.g., blood type A) donates to someone near the top of the deceased donor waiting list. In exchange, this donor's incompatible recipient with a rarer blood type (e.g, blood type O) is placed near the top of the deceased donor waiting list, bypassing many other potential recipients with the rarer blood type. There is some concern that individuals on the waiting list for a rarer blood type will have to wait longer because incompatible recipients are being moved ahead of them. Another type of exchange that may be viewed as controversial is an imbalanced paired donation. This is where a compatible pair, in hopes of receiving a younger kidney or avoiding a high immunologic risk donation, is matched with an incompatible pair thereby resulting in two compatible transplant pairs. 27 This type of exchange has been viewed as unethical among some transplant center directors 28 , possibly because paired donation may not provide any medical benefit to the compatible pair and may take away some emotional benefit of an individual donating directly to a relative.
A variation of non-directed donation includes a non-directed donor starting a chain ( Figure 2 ).
In this process, a non-directed donor donates their kidney to recipient A with an incompatible 
Current programs
Multiple programs around the world have used variations of the exchanges listed above.
National programs include South Korea 30 , Netherlands 31 , and, most recently, Canada. 32 In the United States, several regional networks have been established (Table 1) . 26 Foundation developed and runs the allocation algorithm used to match donor/recipient pairs. 35 The algorithm calculates a match probability for each recipient based on their degree of sensitization by the PRA of the recipient, blood group type, and HLA unacceptable antigens.
The rank list for donor/recipient pairs is then sorted by match probability with the lowest Match runs are conducted monthly if a new pair is entered into the database. The match run has a few rules to ensure mutually agreed-upon, socially equitable exchanges. The match run program will not match donors to a transplant candidate more than 20 years younger than the candidate's incompatible donor. This prevents a transplant candidate from receiving a much younger donor than they brought to the exchange. Donor age has been found to be an important factor in living donor allograft survival. 38 If a match is found, the transplant teams are informed and then they start reviewing the donor characteristics and proceed to an actual cross-match to be conducted by the individual transplant centers.
Recipients participating in some donor exchange programs may be required to accept the anonymity of the donor. In a study of participants of one kidney exchange program, 78% of recipients were satisfied that the procedure had taken place anonymously to avoid extra stress or concerns about the anonymous donor. 39 If the donor wishes to remain anonymous, the transplant center needs to be aware of the logistical issues of keeping the pairs in separate sections of the hospital during the pre-operative and post-operative periods. All this requires intensive work on the part of the transplant coordinator, so much so that other exchange programs found this process to be almost impossible in a single center, and they arrange for the donors and recipients to meet prior to transplant. 40 If donors and recipients in the NCDEC consent to meet, this is arranged among the NCDEC centers. The NCDEC recommends waiting at least until 6 months after the surgery to allow for both recipients to complete the high risk period for acute rejections.
Coordination of the multiple transplants at one time can also consume a significant amount of coordinator time. This is a significant concern, particularly among smaller transplant programs. 41 The process of establishing the NCDEC required input from many of the participating sites, in order to develop a working plan along with programmer support to create a web-based data entry tool and a match run program. The NCDEC also collaborates with other exchange programs in order to maximize the possibility of finding compatible donors for the highly sensitized patients that are participating in the NCDEC. The pilot program for a national exchange program hopes to answer several concerns including donor travel, follow up care and shipping kidneys. With regard to shipping kidneys, some donors may not be able to travel to another state for donation. However, for a national program to succeed, this issue needs to be addressed. One option is for the kidney to travel rather than the donor. The primary concern is that cold-ischemia times would be longer than typical living donor transplants. Waki, et al. looked at living donor kidneys with cold ischemia times ranging from 0-6, 7-12, and 13-24 hours and found no significant difference in graft survival between the group. 42 Simpkins, et al. looked specifically at living donor kidneys with cold ischemia times up to 8 hours. 43 They found higher rates of delayed graft function with increased cold ischemia time, but no difference in serum creatinine, acute rejection, or long-term graft survival. These two studies both concluded that longer cold ischemia times associated with shipping organs will have no detrimental effects. This issue is brought up with the donor and recipient as part of the consent process. The NCDEC and other exchanges work with their local organ procurement organizations to help with the shipping of the living donor organs. As for follow up care, the surgeons at the recipient transplant center participating in the NCDEC were willing to follow donors they did not operate on.
Summary
The shortage of organs has led to innovative methods that allow more patients to undergo kidney transplantation. Kidney paired exchanges, from the simplest two incompatible paired exchange to the complexity of simultaneous multi-way exchanges or extended donor chains, have emerged out of various regional exchange programs in the U.S. As the news media reports paired exchange success stories, 44 patients will be approaching their nephrologists about how they can participate in these programs. The importance of a national program is recognized by UNOS and a pilot program is in development with the hope of a national program by the end of 2010. In the mean time, incompatible recipient-donor pairs can discuss kidney paired donation with their local nephrologists. Some potential questions or issues regarding donor exchange programs are presented in Table 2 . While the specific details of donor exchange programs should be left to the transplant center, the local nephrologist should be aware of the closest transplant center that participates in a regional donor exchange program so their patients can benefit from these programs. The onus for a timely referral to such exchange programs will probably fall on the local nephrologist, however such a referral may greatly benefit the incompatible recipient-donor pairs in their practice. Is it important to refer to a patient to a center that has done many donor exchanges? For logistical reasons, all transplants in a chain need not occur at the same time. The chain may continue endlessly until an incompatible donor decides not to donate and breaks a chain. The chain may be intentionally broken by donating to a patient on the deceased donor waiting list.
When creating an endless chain, it is ideal not to stop a chain at an incompatible donor with AB blood type since that donor's kidney may only be accepted by a AB blood type recipient. Such a recipient with an incompatible donor is rare to find.
